Evaluation of Efficacy and Tolerability of a Fixed dose combination of Eperisone hydrochloride and diclofenac sodium in the treatment of acute musculo-skeltal spasm associated with low back pain: An Observer Blind, Prospective, randomized, controlled study.

Trial Profile

Evaluation of Efficacy and Tolerability of a Fixed dose combination of Eperisone hydrochloride and diclofenac sodium in the treatment of acute musculo-skeltal spasm associated with low back pain: An Observer Blind, Prospective, randomized, controlled study.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Diclofenac/eperisone (Primary) ; Eperisone
  • Indications Musculoskeletal pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Eisai Inc
  • Most Recent Events

    • 18 Feb 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; 99233).
    • 14 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top